Get started
Author

Joaquim Oristrell

Observed names: J Oristrell, J Oristrell Salva, J Oristrell Salvá, J. Oristrell, J. Oristrell Salvà, J. Oristrell Salvá, Joaquim Oristrell Salvà, Joaquín Oristrell, Oristrell I Salvà, Joaquim, Oristrell Salva, Joaquim, Oristrell Salva, Joaquín, Oristrell Salvà, Joaquín, Oristrell, Joaquim, Salvà, Joaquim Oristrell
Observed institutions: Universitat Autònoma de Barcelona, Bellvitge University Hospital, Hospital Clínic de Barcelona, Corporació Sanitària Parc Taulí, Vall d'Hebron Hospital Universitari, Institute of Research and Innovation Parc Tauli, University Hospital Ulm, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Universitat de Barcelona
ORCID: 0000-0003-1486-3192
Observed ORCID: 0000-0003-1486-3192
OpenAlex ID: A5083250797
The Persistent Exclusion of Older Patients From Ongoing Clinical Trials Regarding Heart Failure
2011 · Antonio Cherubini, Joaquim Oristrell, et al. · Archives of Internal Medicine · 373
Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis
1998 · Maria C. Cid, Carme Font, et al. · Arthritis & Rheumatism · 282
Clinical characteristics and outcome of Spanish patients with ANCA-associated vasculitides
2017 · Roser Solans-Laqué, Guadalupe Fraile, et al. · Medicine · 159
Exclusion of Older People from Clinical Trials
2011 · Peter Crome, Frank Lally, et al. · Drugs & Aging · 149
Off-label use of rituximab in 196 patients with severe, refractory systemic autoimmune diseases.
2010 · M Ramos-Casals, F J García-Hernández, et al. · PubMed · 140
Vitamin D supplementation and COVID-19 risk: a population-based, cohort study
2021 · J. Oristrell, J. C. Oliva, et al. · Journal of Endocrinological Investigation · 133
PDF
Rates of, and risk factors for, severe infections in patients with systemic autoimmune diseases receiving biological agents off-label
2011 · Cándido Díaz-Lagares, Roberto Pérez-Alvarez, et al. · Arthritis Research & Therapy · 71
PDF
Off-label use of rituximab for systemic lupus erythematosus in Europe
2016 · Monica Rydén-Aulin, Dimitrios Boumpas, et al. · Lupus Science & Medicine · 69
The PREDICT (increasing the participation of the elderly in clinical trials) study: the charter and beyond
2014 · Peter Crome, Antonio Cherubini, et al. · Expert Review of Clinical Pharmacology · 62
Circulating soluble adhesion molecules in patients with giant cell arteritis. Correlation between soluble intercellular adhesion molecule-1 (sICAM-1) concentrations and disease activity
1999 · Blanca Coll-Vinent, Carme Vilardell, et al. · Annals of the Rheumatic Diseases · 61
PDF
Reactive Perforating Collagenosis in Hodgkinʼs Disease
1987 · Ramón Pedragosa, Hernando J. Knobel, et al. · American Journal of Dermatopathology · 48
Comparison of the Birmingham Vasculitis Activity Score and the Five‐Factor Score to Assess Survival in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: A Study of 550 Patients From Spain (REVAS Registry)
2019 · Roser Solans‐Laqué, Monica Rodriguez‐Carballeira, et al. · Arthritis Care & Research · 47
Analysis of temporal artery biopsies in an 18-year period at a community hospital
2009 · B. Marí, M. Monteagudo, et al. · European Journal of Internal Medicine · 45
Safety and effectiveness of outpatient parenteral antimicrobial therapy in older people
2016 · Abel Mujal, Joan Sola, et al. · Journal of Antimicrobial Chemotherapy · 36
Von Willebrand factor in the outcome of temporal arteritis.
1996 · M.C Cid, J Monteagudo, et al. · Annals of the Rheumatic Diseases · 36
PDF
Association of Calcitriol Supplementation with Reduced COVID-19 Mortality in Patients with Chronic Kidney Disease: A Population-Based Study
2021 · Joaquim Oristrell, Joan C. Oliva, et al. · Biomedicines · 34
PDF
Circulating soluble adhesion molecules in patients with classical polyarteritis nodosa
1997 · B. Coll-Vinent, J. M. Grau, et al. · Rheumatology · 29
Corticosteroids and tocilizumab reduce in-hospital mortality in severe COVID-19 pneumonia: a retrospective study in a Spanish hospital
2021 · E. Van den Eynde, O. Gasch, et al. · Scandinavian Journal of Infectious Diseases · 28
Relapse rate and renal prognosis in ANCA-associated vasculitis according to long-term ANCA patterns
2020 · J Oristrell, J Loureiro-Amigo, et al. · Clinical & Experimental Immunology · 23
Safety and effectiveness of home intravenous antibiotic therapy for multidrug-resistant bacterial infections
2015 · A. Mujal, J. Sola, et al. · European Journal of Clinical Microbiology & Infectious Diseases · 23
Release of soluble tumor necrosis factor receptors in Mediterranean spotted fever rickettsiosis
1996 · W V Kern, J Oristrell, et al. · Clinical and Diagnostic Laboratory Immunology · 21
Giant cell (temporal) arteritis and secondary renal amyloidosis: report of 2 cases.
1997 · M Monteagudo, G Vidal, et al. · PubMed · 19
Plasma Levels of Tumor Necrosis Factor in Patients with Mediterranean Spotted Fever: Clinical and Analytical Correlations
1994 · J. Oristrell, M. {a. } J. Amengual, et al. · Clinical Infectious Diseases · 18
Bleeding in Patients With Lupus Anticoagulant
1984 · J. Ordi, M. Vilardel, et al. · The Lancet · 17
Eficacia Y Seguridad Del Tratamiento Antibiótico Domiciliario Endovenoso En Patologia Infecciosa Procedente Del Servicio De Urgencias
2013 · Abel Mujal Martínez, Joan Solá Aznar, et al. · Emergencias · 15
Works count: 77
Citation count: 2,013
H-index: 21
I10-index: 26
Year
Topic
Type